Close Menu

microbial sequencing

The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.

The companies are aiming to use microbial biomarkers to predict the development of precancerous adenomas and carcinomas.

The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.